160 related articles for article (PubMed ID: 16556052)
1. Temozolomide: a milestone in the pharmacotherapy of brain tumors.
Weller M; Steinbach JP; Wick W
Future Oncol; 2005 Dec; 1(6):747-54. PubMed ID: 16556052
[TBL] [Abstract][Full Text] [Related]
2. Temozolomide: a milestone in neuro-oncology and beyond?
Mutter N; Stupp R
Expert Rev Anticancer Ther; 2006 Aug; 6(8):1187-204. PubMed ID: 16925485
[TBL] [Abstract][Full Text] [Related]
3. Anti-glioma therapy with temozolomide and status of the DNA-repair gene MGMT.
Fukushima T; Takeshima H; Kataoka H
Anticancer Res; 2009 Nov; 29(11):4845-54. PubMed ID: 20032445
[TBL] [Abstract][Full Text] [Related]
4. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
[TBL] [Abstract][Full Text] [Related]
5. Optimal role of temozolomide in the treatment of malignant gliomas.
Stupp R; van den Bent MJ; Hegi ME
Curr Neurol Neurosci Rep; 2005 May; 5(3):198-206. PubMed ID: 15865885
[TBL] [Abstract][Full Text] [Related]
6. Temozolomide in malignant gliomas.
Yung WK
Semin Oncol; 2000 Jun; 27(3 Suppl 6):27-34. PubMed ID: 10866347
[TBL] [Abstract][Full Text] [Related]
7. Temozolomide in malignant gliomas: current use and future targets.
Villano JL; Seery TE; Bressler LR
Cancer Chemother Pharmacol; 2009 Sep; 64(4):647-55. PubMed ID: 19543728
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.
Mirimanoff RO; Gorlia T; Mason W; Van den Bent MJ; Kortmann RD; Fisher B; Reni M; Brandes AA; Curschmann J; Villa S; Cairncross G; Allgeier A; Lacombe D; Stupp R
J Clin Oncol; 2006 Jun; 24(16):2563-9. PubMed ID: 16735709
[TBL] [Abstract][Full Text] [Related]
9. Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.
Gorlia T; van den Bent MJ; Hegi ME; Mirimanoff RO; Weller M; Cairncross JG; Eisenhauer E; Belanger K; Brandes AA; Allgeier A; Lacombe D; Stupp R
Lancet Oncol; 2008 Jan; 9(1):29-38. PubMed ID: 18082451
[TBL] [Abstract][Full Text] [Related]
10. New trends in the medical management of glioblastoma multiforme: the role of temozolomide chemotherapy.
Dehdashti AR; Hegi ME; Regli L; Pica A; Stupp R
Neurosurg Focus; 2006 Apr; 20(4):E6. PubMed ID: 16709037
[TBL] [Abstract][Full Text] [Related]
11. Role of temozolomide in pediatric brain tumors.
Barone G; Maurizi P; Tamburrini G; Riccardi R
Childs Nerv Syst; 2006 Jul; 22(7):652-61. PubMed ID: 16565851
[TBL] [Abstract][Full Text] [Related]
12. [Temozolomide: Temodal].
Shinoura N; Yamada R; Tabei Y; Saito K; Nakamura O; Takahashi M
Gan To Kagaku Ryoho; 2008 Mar; 35(3):543-7. PubMed ID: 18347414
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of O6-methylguanine-DNA methyltransferase protein expression in patients with recurrent glioblastoma treated with temozolomide.
Nagane M; Kobayashi K; Ohnishi A; Shimizu S; Shiokawa Y
Jpn J Clin Oncol; 2007 Dec; 37(12):897-906. PubMed ID: 18156172
[TBL] [Abstract][Full Text] [Related]
14. Temozolomide and treatment of malignant glioma.
Friedman HS; Kerby T; Calvert H
Clin Cancer Res; 2000 Jul; 6(7):2585-97. PubMed ID: 10914698
[TBL] [Abstract][Full Text] [Related]
15. [Prescription guidebook for temozolomide usage in brain tumors].
Tilleul P; Brignone M; Hassani Y; Taillandier L; Taillibert S; Cartalat-Carel S; Borget I; Chinot O
Bull Cancer; 2009 May; 96(5):579-89. PubMed ID: 19467988
[TBL] [Abstract][Full Text] [Related]
16. Future directions in the treatment of malignant gliomas with temozolomide.
Prados MD
Semin Oncol; 2000 Jun; 27(3 Suppl 6):41-6. PubMed ID: 10866349
[TBL] [Abstract][Full Text] [Related]
17. Should concomitant and adjuvant treatment with temozolomide be used as standard therapy in patients with anaplastic glioma?
Siker ML; Chakravarti A; Mehta MP
Crit Rev Oncol Hematol; 2006 Nov; 60(2):99-111. PubMed ID: 17027279
[TBL] [Abstract][Full Text] [Related]
18. Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme.
Athanassiou H; Synodinou M; Maragoudakis E; Paraskevaidis M; Verigos C; Misailidou D; Antonadou D; Saris G; Beroukas K; Karageorgis P
J Clin Oncol; 2005 Apr; 23(10):2372-7. PubMed ID: 15800329
[TBL] [Abstract][Full Text] [Related]
19. [Standards and new developments in the chemotherapy of glioblastomas].
Weller M
Dtsch Med Wochenschr; 2005 Oct; 130(40):2270-4. PubMed ID: 16208603
[TBL] [Abstract][Full Text] [Related]
20. Recent approaches to improve the antitumor efficacy of temozolomide.
Tentori L; Graziani G
Curr Med Chem; 2009; 16(2):245-57. PubMed ID: 19149575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]